CellCarta Science Hub

Featured Press Releases

CellCarta Expands its Biomarker Capabilities for Clinical Trials by adding Olink Technology to its Global Services

Proteomics/Mass Spectrometry

More info

Press Releases

CellCarta acquires Reveal Biosciences

Histopathology

More info

Featured Press Releases

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta

More info

CellTalk

What steps to follow when developing multiplex IHC assays

More info

MOSAIC Laboratories - A CellCarta Company

Quantification of sBCMA in Human Plasma using a High-Throughput Hybrid IP-MRM Based Mass Spectrometry Workflow

July 27, 2021

Proteomics/Mass Spectrometry

More info

Posters

Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues

November 9, 2020

Proteomics/Mass Spectrometry

More info

Posters

Monitoring MDSC – A Hurdle to Immune Checkpoints Inhibitors

November 9, 2020

Flow Cytometry

More info

Posters

Multiple Myeloma Flow Cytometry Panel Validated for Clinical Monitoring of Patients

November 9, 2020

Flow Cytometry

More info

Posters

Quantification of sBCMA in Human Plasma using a High-Throughput Mass Spectrometry Workflow for Exploratory, CAP/CLIA or Regulated Studies

November 9, 2020

Proteomics/Mass Spectrometry

More info

Posters

MDSC: Inhibiting Immune Therapy

July 29, 2020

Immune Monitoring

More info

Posters

Evaluation and implementation of an automated fluidic instability clean-up tool

July 29, 2020

Immune Monitoring

More info

Posters

Clinical Proteomics for Patient Stratification – A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

July 29, 2020

Proteomics/Mass Spectrometry

More info

Posters

High Throughput Automated Workflow for the Analysis of MHC-I and MHC-II Samples by LC-MS/MS

November 20, 2019

Proteomics/Mass Spectrometry

More info

Show the filters